Receptor de Canabinóides
Os receptores de canabinoides são GPCRs que mediam os efeitos dos canabinoides endógenos (endocanabinoides) e dos fitocanabinoides, como aqueles encontrados na cannabis. Os dois principais tipos de receptores de canabinoides, CB1 e CB2, estão envolvidos na regulação de uma ampla gama de processos fisiológicos, incluindo percepção da dor, apetite, humor e função imunológica. Moduladores de receptores de canabinoides têm potencial terapêutico no tratamento de condições como dor crônica, epilepsia e esclerose múltipla. Na CymitQuimica, oferecemos uma ampla gama de moduladores de receptores de canabinoides de alta qualidade para apoiar sua pesquisa em neurofarmacologia, manejo da dor e imunologia.
Foram encontrados 223 produtos para "Receptor de Canabinóides".
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
CB2R/FAAH modulator-3
CAS:CB2R/FAAH modulator-3 (compound 27) is a modulator targeting at CB2R and FAAH.Fórmula:C22H31NO2Pureza:99.81%Cor e Forma:SolidPeso molecular:341.49Rimonabant hydrochloride
CAS:Rimonabant hydrochloride (SR 141716A) 是中心大麻素受体 1 的高效选择性反向激动剂， Ki 值为1.8 nM。它也能够抑制分枝杆菌膜蛋白3。Fórmula:C22H22Cl4N4OPureza:98.24% - 99.88%Cor e Forma:Off-White To White Crystalline PowderPeso molecular:500.256-Iodopravadoline
CAS:6-Iodopravadoline (AM630) is an antagonist of CB2 (Ki: 31.2 nM). And it shows 165-fold selectivity more than CB1 receptors.Fórmula:C23H25IN2O3Pureza:99.29%Cor e Forma:SolidPeso molecular:504.36Ref: TM-T14204
1mg38,00€2mg52,00€5mg70,00€10mg90,00€1mL*10mM (DMSO)99,00€25mg198,00€50mg326,00€100mg520,00€Pregnenolone
CAS:Pregnenolone (Arthenolone) is an endogenous steroid hormone synthesized from cholesterol, used in the treatment of Alzheimer's disease.Fórmula:C21H32O2Pureza:99.5% - 99.84%Cor e Forma:SolidPeso molecular:316.48Anandamide
CAS:Anandamide ((5Z,8Z,11Z,14Z)-N-(2-Hydroxyethyl)icosa-5,8,11,14-tetraenamide), an immune modulator, acts via not only cannabinoid receptors (CB1 and CB2) but alsoFórmula:C22H37NO2Pureza:95.03% - 99.22%Cor e Forma:Light Yellow OilPeso molecular:347.53Ref: TM-T14046
1mg34,00€2mg46,00€5mg67,00€1mL*10mM (DMSO)73,00€10mg117,00€25mg221,00€50mg330,00€100mg485,00€Rimonabant
CAS:Rimonabant (SR141716) is an inverse agonist for the cannabinoid receptor CB1.Fórmula:C22H21Cl3N4OPureza:98% - 99.91%Cor e Forma:White SolidPeso molecular:463.79EHP-101
CAS:EHP-101 is a PPARγ/CB2 dual agonist with anti-inflammatory properties, inhibits fat formation, and combats diet-related obesity.Fórmula:C28H35NO3Pureza:98.36%Cor e Forma:SolidPeso molecular:433.58Ref: TM-T13289
1mg101,00€5mg178,00€1mL*10mM (DMSO)203,00€10mg295,00€25mg485,00€50mg677,00€100mg888,00€JHU 75528
CAS:JHU 75528 (JHU-75528) is a novel PET tracer with inhibitory effects on CB that can be used to study the cannabinoid system in schizophrenic patients.Fórmula:C23H21Cl2N5O2Pureza:99.79%Cor e Forma:White SolidPeso molecular:470.35CB1 antagonist 2
CAS:CB1 antagonist 2 (AM4113) is caimabinoid 1 (CB1) antagonist which inhibits CB1 in vivo with an IC50 of 25.5 nM.Fórmula:C17H12Cl3N3OPureza:99.75%Cor e Forma:SolidPeso molecular:380.66Vicasinabin
CAS:Vicasinabin: potent CB2 agonist; researches chronic pain, atherosclerosis, bone mass, neuroinflammation.Fórmula:C15H22N10OCor e Forma:SolidPeso molecular:358.41UVI3502
UVI3502 is a cannabinoid receptor 1 (CB1) antagonist with an IC50 value of 4641 nM for CB1 and approximately 16200 nM for CB2. It can inhibit Gi/o protein coupling induced by the agonist CP55,940. UVI3502 shows potential for research into diseases related to the endocannabinoid system in the central nervous system, such as cognitive impairments and neurodegenerative disorders.Tocrifluor T1117
CAS:Fluorescent form of AM 251, CB1 receptor antagonistFórmula:C56H53Cl2N7O5Pureza:98%Cor e Forma:SolidPeso molecular:974.97CB2R/FAAH modulator-1
CAS:CB2R/FAAH modulator-1: agonizes CB2R, inhibits FAAH (IC50=4 μM), alters cytokine production; used in inflammation research. Ki: CB2R=14.8 nM, CB1R=241.3 nM.Fórmula:C24H27NO2Pureza:99.77%Cor e Forma:SolidPeso molecular:361.48Ref: TM-T67896
1mg50,00€5mg105,00€1mL*10mM (DMSO)108,00€10mg154,00€25mg224,00€50mg314,00€100mg427,00€200mg575,00€Nervonoyl ethanolamide
CAS:Nervonoyl ethanolamide (NEA), an endogenous cannabinoid, functions as both a presynaptic and postsynaptic neuromodulator. Additionally, it is utilized in inflammation research [1].Fórmula:C26H51NO2Cor e Forma:SolidPeso molecular:409.69Hemopressin(rat)
CAS:Peptide inhibitor for ep24.15, neurolysin & ACE with Ki 27.76, 3.43, 1.87 μM. Lowers blood pressure, modulates CB1 receptor, reduces pain & food intake.Fórmula:C53H77N13O12Pureza:98%Cor e Forma:SolidPeso molecular:1088.27N-(1-(3,4-Dihydroxyphenyl)propan-2-yl)oleamide
CAS:N-(1-(3,4-Dihydroxyphenyl)propan-2-yl)oleamide: binds CB1 (Ki=365 nM), activates PPARα (EC50=698 nM), reduces rat food intake, no FAAH inhibition.Fórmula:C27H45NO3Cor e Forma:SolidPeso molecular:431.661CB2R probe 1
CAS:CB2R Probe 1, a cannabinoid 2 receptor (CB2R) fluorescent probe, exhibits both safety and environmental friendliness, boasting a dissociation constant (K i) ofFórmula:C36H42N4O4Cor e Forma:SolidPeso molecular:594.74SCOTfluor-89
CAS:SCOTfluor-89 is a small, conjugatable, orthogonal, and multicolor fluorescent group designed for in vivo imaging of cell metabolism.Fórmula:C12H14N4O7SeCor e Forma:SolidPeso molecular:405.22TRPM8 antagonist 4 prodrug
TRPM8 antagonist 4 prodrug (Compound 8b) is an orally active CB2R agonist (EC50: 51.2 nM) and a weak TRPM8 antagonist. It acts as a prodrug of TRPM8 antagonist 4, exhibiting anti-inflammatory and analgesic properties. TRPM8 antagonist 4 prodrug is applicable in studies of inflammation-related pain disorders.(R)-Zevaquenabant
(R)-Zevaquenabant ((R)-MRI-1867) is the enantiomer of Zevaquenabant. Zevaquenabant ((S)-MRI-1867) is a peripherally restricted, orally bioavailable dual antagonist of the cannabinoid CB1 receptor and inducible nitric oxide synthase (iNOS). It is beneficial in improving chronic kidney disease (CKD) caused by obesity.Cor e Forma:Odour Solid
